Vanessa Debruin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Medtronic faced tough questions about its Symplicity Spyral renal denervation (RDN) therapy for hypertension at today's FDA review panel.

United statesSymplicity spyralMatthew corriereEric batesBen savilleVanessa debruinBram zuckermanRadiological healthOffice of cardiovascular devicesAmerican heart associationUniversity of michiganOtsuka medical device recorBerry consultantsCardiovascular devices